• Consultant of Cardiology and Internal Medicine
• Founder and past director of the Advanced Heart Failure and Transplantation units in Chest Hospital and Dabbous cardiac center
• Gold member in the European Society of Cardiology (ESC)
• Practicing at Al-Salam Hospital and Al-Ahmadi Hospital - KOC University of Chicago Medicine

Associate Professor Dirk Blom (MBChB, MMed, FCP (SA), PhD) is the Head of Division of Lipidology in the Department of Medicine at the University of Cape Town and heads the Lipid Clinic at Groote Schuur Hospital.

Dr Blom’s personal research interests include genetic disorders of lipoprotein metabolism with a particular emphasis on dysbetalipoproteinaemia and familial hypercholesterolaemia which is particularly common in South Africa. His unit has participated or is participating in multiple trials of novel agents for the management of heterozygous and homozygous familial hypercholesterolaemia, familial chylomicronaemia and atherogenic dyslipidaemia. Other interests include familial chylomicronaemia syndrome, lipodystrophy, PPARgamma mutations and statin associated muscle symptoms.

Dr Blom is a member of multiple international societies and currently serves on the executive committee of the Lipid and Atherosclerosis Society of Southern Africa. He is the current President of the International Atherosclerosis Society.

Dr. Ahmad Esmaeel obtained his medical degree with honors from the Royal College of Surgeons in Dublin, Ireland. He then trained in France where he obtained his residency in Endocrinology, Diabetes and Metabolic Disease.

Dr. Ahmad's interest lies in Diabetes and Obesity management.

• H. professor Cardiology at umm Al-Qora University
• Chairman Of Non-Invasive Cardiac Service at Al Noor Specialist Hospital, Makkah
• Fellowship Cardiology Program Director, Examiner & Reviewer
• Membership Of Critical Care Medicine Paris - France
• FCCS Instructure- California - USA

Dr. Lansberg is a lipidologists and senior staff member at the Department of Pediatrics, Section Molecular Genetics University Medical Centre Groningen, the Netherlands.

Dr. Lansberg obtained his Bachelor, Master and Doctor of Medicine degrees from University of Amsterdam (UvA). He returned to Academic Medical Center (AMC) where he worked on his doctoral thesis “The Molecular Basis and Treatment of Familial Hypercholesterolemia (FH)” at the department of vascular Medicine under the supervision of prof. John Kastelein and prof. Jan Wouter ten Cate. During this period he was involved in a large number of clinical trials focusing on lipid management and genetic research at the department of vascular Medicine

• Established and supervised, in collaboration with Prof. John Kastelein, the Amsterdam Lipid Clinic in the Slotervaart medical center in Amsterdam
• Conceived and developed the first electronic health record for the registration of patients with lipid abnormalities.
• Co-founder, in collaboration with Prof. John Kastelein, of the Dutch Lipid Clinic Network, a national alliance of lipid expertise centers in the Dutch academic and general hospitals.
• Scientific advisory board of the international ‘Make Early Diagnosis to Prevent Early Death’ (MedPed) program.
• Founder and former director of the Dutch National FH Cascade Screening program (Stichting Opsporing Erfelijke Hypercholesterolemie (StOEH). Based on this experience and expertise he supported similar initiatives in Europe, Middle East, Southeast Asia, Canada, Australia and New Zealand

Dr. Muneera Altarrah is a Consultant Transplant Hepatologist and Gastroenterologist at Amiri Hospital, Kuwait. She is dedicated to patient care, academic teaching, and clinical research, with particular expertise in metabolic dysfunction-associated liver disease (MAFLD), viral hepatitis, and post-liver transplant management. In addition to her clinical responsibilities, Dr. Altarrah is actively involved in resident education. Her research interests include the use of GLP-1 receptor agonists in liver transplant recipients and national initiatives for hepatitis D screening.

Dr. Abdulhamied Alfaddagh is an Interventional Cardiologist at Jaber Al-Ahmad Hospital, Ministry of Health, Kuwait. Additionally, he serves as a Clinical Tutor for the Kuwait board of Internal Medicine at the Kuwait Institute of Medical Specialization

He is a preventive cardiologist at the Academic Research Organization (ARO) of the Hospital Albert Einstein in São Paulo, Brazil. Additionally, he is an associate professor and director of the Lipid Clinic at the Heart Institute (InCor) of the University of São Paulo Medical School Hospital. His research focuses on lipid metabolism, severe genetic dyslipidemias—particularly familial hypercholesterolemia—imaging in atherosclerosis, and novel lipid-lowering therapies, especially in pediatric patients. He was the president of the International Atherosclerosis Society (IAS) from 2019 to 2021 and is currently the Editor-in-Chief of Global Heart, the official journal of the World Heart Federation (WHF). He has published more than 450 papers in peer-reviewed journals and has been recognized as one of the Clarivate Analytics Highly Cited Researchers since 2021.

• Consultant and the Head Endocrinology, Diabetes and Metabolism Division, Jaber Al-Ahmad Hospital
• Clinical Staff at Dasman Diabetes Institute

Dr. Nasir received his MD from Pakistan, followed by a MPH at Johns Hopkins University. Dr. Nasir completed his internal medicine residency at Boston Medical Center and a cardiology fellowship at Yale University. He also received postdoctoral research training at the division of cardiology at John's Hopkins Hospital, and was the recipient of NIH - T-32 fellowship in cardiac imaging at Massachusetts General Hospital. He recently earned a Master’s degree in health economics and Policy Management.

Bassam Bulbanat is Consultant of Cardiology (echocardiography specialist) at the Sabah Al Ahmad Cardiac Center, Ministry of health, Kuwait. During his academic career he has contributed to several international journal publications. He is the program director of the Adult Cardiology Fellowship Program affiliated with KIMS.

Dr. Nawal graduated from the Kuwait University School of Medicine in 2014. She completed her internship in Farwaniya hospital and then completed IM residency and Endocrinology fellowship in Vancouver, Canada at the University of British Columbia. She is currently working as an endocrinologist at Jaber Hospital with a special interest in pituitary and adrenal disease.

Dr. Nawal is a faculty member at Kuwait University, currently working as a clinical tutor. She is also the Kuwait Board of Internal Medicine (KBIM) Assistant Program Director for residents’ affairs. She is the Kuwait Board of Internal Medicine Residents’ Wellness Lead for the past two years, with a focus on struggling residents.